Naproxen Infectopharm 50 mg/ml Suspension zum Einnehmen Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

naproxen infectopharm 50 mg/ml suspension zum einnehmen

Colistimethat-Natrium Infectopharm 1 Mio. I.E. Pulver zur Herstellung einer Injektions- oder Infusionslösung Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

colistimethat-natrium infectopharm 1 mio. i.e. pulver zur herstellung einer injektions- oder infusionslösung

TobraZid INFECTOPHARM 40 mg/1 ml Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

tobrazid infectopharm 40 mg/1 ml

TobraZid INFECTOPHARM 80 mg/2 ml Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

tobrazid infectopharm 80 mg/2 ml

Permethrin Infectopharm 50 mg/g Creme Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

permethrin infectopharm 50 mg/g creme

Colistimethat-Natrium Infectopharm 3 Million I.E Pulver zur Herstellung einer Infusionslösung Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

colistimethat-natrium infectopharm 3 million i.e pulver zur herstellung einer infusionslösung

Amisulpride 200mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

amisulpride 200mg tablets

sigma pharmaceuticals plc - amisulpride - oral tablet - 200mg

Amisulpride 400mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

amisulpride 400mg tablets

sigma pharmaceuticals plc - amisulpride - oral tablet - 400mg

Circadin European Union - English - EMA (European Medicines Agency)

circadin

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders - psycholeptics - circadin is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Slenyto European Union - English - EMA (European Medicines Agency)

slenyto

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders; autistic disorder - psycholeptics - slenyto is indicated for the treatment of insomnia in children and adolescents aged 2-18 with autism spectrum disorder (asd) and / or smith-magenis syndrome, where sleep hygiene measures have been insufficient.